文献速递血液净化与透析肾移植

使用PROMIS计算机自适应测试评估接受肾脏替代治疗患者的疲劳

Assessing Fatigue in Patients Receiving Kidney Replacement Therapy Using PROMIS Computer Adaptive Testing.
PubMed 文献 · Am J Kidney Dis · 2023-03-09

该横断面研究纳入加拿大多伦多198例接受透析或肾移植的成人,以FACIT-F为参照评估PROMIS-F CAT的测量特性。PROMIS-F CAT与FACIT-F强相关(ρ=-0.80,P<0.001),重测信度ICC=0.85,ROC曲线下面积0.93(95%CI 0.89-0.97)。PROMIS-F CAT cutoff≥59识别临床相关疲劳的敏感度0.83、特异度0.91。

要点

  • PROMIS-F CAT与FACIT-F强相关(ρ=-0.80,P<0.001),信度良好(ICC=0.85)。
  • PROMIS-F CAT cutoff≥59识别临床相关疲劳的敏感度0.83、特异度0.91。
  • PROMIS-F CAT在肾脏替代治疗患者中测量特性稳健且问题负担低。

核心结论

  • PROMIS-F CAT在肾脏替代治疗患者中具有稳健的测量特性且问题负担低,可用于评估疲劳。

研究设计与样本

  • 横断面研究,纳入加拿大多伦多198例接受透析或肾移植的成人。

主要发现

  • 198例中57%为男性,平均±SD年龄57±14岁,65%接受肾移植。
  • 基于FACIT-F评分,47例(24%)存在临床相关疲劳。
  • PROMIS-F CAT与FACIT-F强相关(ρ=-0.80,P<0.001)。
  • PROMIS-F CAT信度优秀(98%样本>0.90),重测信度良好(ICC=0.85)。
  • ROC分析显示区分度出色(ROC曲线下面积=0.93[95%CI 0.89-0.97])。

关键数值与推荐

  • 临床相关疲劳定义为FACIT-F评分≤30。
  • PROMIS-F CAT cutoff≥59准确识别多数临床相关疲劳患者(敏感度=0.83;特异度=0.91)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 便利样本,患者临床稳定。
  • FACIT-F条目是PROMIS-F条目库的一部分,但仅4个FACIT-F条目在PROMIS-F CAT中完成,重叠极小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Fatigue is a debilitating symptom for many patients receiving kidney replacement therapy (KRT). Patient-reported outcome measures can help clinicians identify and manage fatigue efficiently. We assessed the measurement characteristics of the Patient Reported Outcome Measurement Information System (PROMIS)-Fatigue Computer Adaptive Test (PROMIS-F CAT) in patients receiving KRT using the previously validated Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) questionnaire. STUDY DESIGN: Cross-sectional study. SETTING & PARTICIPANTS: 198 adults treated with dialysis or recipients of a kidney transplant in Toronto, Canada. PREDICTORS: Demographic data, FACIT-F scores, KRT type. OUTCOME: Measurement properties of PROMIS-F CAT T scores. ANALYTICAL APPROACH: Reliability and test-retest reliability were assessed using standard errors of measurement and intraclass correlation coefficient (ICC), respectively. Construct validity was assessed using correlation and comparisons across predefined groups expected to have different levels of fatigue. Receiver operating characteristic (ROC) curves were used to assess the discrimination of PROMIS-F CAT, with clinically relevant fatigue defined by a FACIT-F score of≤30. RESULTS: Of the 198 participants, 57% were male, the mean±SD age was 57±14 years; 65% had received a kidney transplant. Based on the FACIT-F score, 47 patients (24%) had clinically relevant fatigue. PROMIS-F CAT and FACIT-F were strongly correlated (ρ =-0.80, P<0.001). PROMIS-F CAT had excellent reliability (>0.90 for 98% of sample), and good test-retest reliability (ICC=0.85). The ROC analysis demonstrated outstanding discrimination (area under ROC=0.93 [95%, CI 0.89-0.97]). A PROMIS-F CAT cutoff score of≥59 accurately identified most patients with clinically relevant fatigue (sensitivity=0.83; specificity=0.91). LIMITATIONS: A convenience sample of clinically stable patients. FACIT-F items are a part of the PROMIS-F item bank, although there was minimal overlap with only 4 FACIT-F items completed in PROMIS-F CAT. CONCLUSIONS: PROMIS-F CAT has robust measurement properties with low question burden to assess fatigue among patients with KRT.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Dano S, Hussain J, Edwards N, et al. Assessing Fatigue in Patients Receiving Kidney Replacement Therapy Using PROMIS Computer Adaptive Testing. Am J Kidney Dis. 2023. PMID: 36906218. doi:10.1053/j.ajkd.2022.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。